{
    "2021-07-22": [
        [
            {
                "time": "2021-07-23",
                "original_text": "Danaher Beats on Earnings and Sales. Itâ€™s Ready to Handle a Covid-19 Resurgence.",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Earnings",
                        "Sales",
                        "Covid-19",
                        "Resurgence"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-23",
                "original_text": "Danaher Corporation (DHR) Q2 2021 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Danaher Corporation",
                        "Q2",
                        "Earnings",
                        "Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-23",
                "original_text": "Danaher (DHR) Beats on Q2 Earnings, Ups 2021 Core Sales View",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Q2",
                        "Earnings",
                        "Core Sales",
                        "Ups"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-23",
                "original_text": "Danaher (DHR) Tops Q2 Earnings and Revenue Estimates",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Q2",
                        "Earnings",
                        "Revenue",
                        "Estimates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-23",
                "original_text": "Danaher Reports Second Quarter 2021 Results",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Second Quarter",
                        "2021",
                        "Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}